Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7571722rdf:typepubmed:Citationlld:pubmed
pubmed-article:7571722lifeskim:mentionsumls-concept:C0004623lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0006644lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0085489lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0039005lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0000970lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0003420lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0021234lld:lifeskim
pubmed-article:7571722lifeskim:mentionsumls-concept:C0449297lld:lifeskim
pubmed-article:7571722pubmed:issue5lld:pubmed
pubmed-article:7571722pubmed:dateCreated1995-11-8lld:pubmed
pubmed-article:7571722pubmed:abstractText1. In order to investigate the effect of a bacterial acute phase response model on drug disposition in vivo, plasma clearances of antipyrine, caffeine, paracetamol and indocyanine green were investigated in the healthy and Actinobacillus pleuropneumoniae-infected pig. 2. Indocyanine green plasma and endogenous creatinine clearance were not changed during the infection, which indicates that hepatic blood flow and renal function were not significantly affected. 3. In the A. pleuropneumoniae-infected pig, plasma clearances of antipyrine and caffeine, both marker substrates for hepatic oxidative biotransformation, were decreased by 72 and 68% respectively. The clearance of paracetamol, a drug mainly glucuronidated in the pig, was reduced by 39%. 4. It is concluded that the most important change in drug elimination during an acute phase response induced by A. pleuropneumoniae is a suppression of oxidative hepatic biotransformation.lld:pubmed
pubmed-article:7571722pubmed:languageenglld:pubmed
pubmed-article:7571722pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:citationSubsetIMlld:pubmed
pubmed-article:7571722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7571722pubmed:statusMEDLINElld:pubmed
pubmed-article:7571722pubmed:monthMaylld:pubmed
pubmed-article:7571722pubmed:issn0049-8254lld:pubmed
pubmed-article:7571722pubmed:authorpubmed-author:Van MiertA...lld:pubmed
pubmed-article:7571722pubmed:authorpubmed-author:VerheijdenJ...lld:pubmed
pubmed-article:7571722pubmed:authorpubmed-author:WitkampR FRFlld:pubmed
pubmed-article:7571722pubmed:authorpubmed-author:NijmeijerS...lld:pubmed
pubmed-article:7571722pubmed:authorpubmed-author:PijpersAAlld:pubmed
pubmed-article:7571722pubmed:authorpubmed-author:MonshouwerMMlld:pubmed
pubmed-article:7571722pubmed:issnTypePrintlld:pubmed
pubmed-article:7571722pubmed:volume25lld:pubmed
pubmed-article:7571722pubmed:ownerNLMlld:pubmed
pubmed-article:7571722pubmed:authorsCompleteYlld:pubmed
pubmed-article:7571722pubmed:pagination491-9lld:pubmed
pubmed-article:7571722pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:meshHeadingpubmed-meshheading:7571722-...lld:pubmed
pubmed-article:7571722pubmed:year1995lld:pubmed
pubmed-article:7571722pubmed:articleTitleSelective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig.lld:pubmed
pubmed-article:7571722pubmed:affiliationDepartment of Veterinary Basic Sciences, University of Utrecht, The Netherlands.lld:pubmed
pubmed-article:7571722pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7571722pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7571722lld:pubmed